{"acute coronary syndrome": 19.11, "acute myocardial infarction": 8.69, "alopecia": 2.82, "amylase increased": 11.34, "anaemia": 2.04, "angina pectoris": 3.66, "arteriosclerosis": 8.98, "atrial fibrillation": 2.86, "blast crisis in myelogenous leukaemia": 218.72, "blood bilirubin increased": 13.18, "bone marrow failure": 8.06, "carotid artery stenosis": 42.51, "cerebral infarction": 3.41, "cerebrovascular accident": 2.48, "chronic myeloid leukaemia": 143.84, "chronic myeloid leukaemia recurrent": 337.83, "chronic myeloid leukaemia transformation": 342.0, "coronary artery disease": 4.92, "coronary artery stenosis": 36.73, "cytogenetic analysis abnormal": 585.92, "cytopenia": 21.02, "diabetes mellitus": 2.92, "drug intolerance": 25.45, "drug resistance": 27.64, "dysarthria": 2.23, "electrocardiogram qt prolonged": 16.19, "haematotoxicity": 22.0, "hepatotoxicity": 15.29, "hyperbilirubinaemia": 19.74, "hypercholesterolaemia": 15.63, "intermittent claudication": 146.89, "ischaemic stroke": 4.84, "lipase increased": 17.03, "malignant neoplasm progression": 6.07, "myocardial infarction": 3.08, "myocardial ischaemia": 14.29, "neutropenia": 2.74, "pancreatitis": 4.55, "pancreatitis acute": 5.47, "pancytopenia": 6.43, "pericardial effusion": 8.5, "peripheral arterial occlusive disease": 218.7, "peripheral artery occlusion": 47.01, "peripheral artery stenosis": 317.83, "peripheral vascular disorder": 20.39, "philadelphia chromosome positive": 152.33, "platelet count decreased": 3.2, "pleural effusion": 6.63, "product use in unapproved indication": 6.33, "pulmonary hypertension": 4.97, "second primary malignancy": 34.56, "skin lesion": 3.52, "splenomegaly": 10.55, "therapeutic response decreased": 13.41, "therapy non-responder": 10.3, "thrombocytopenia": 7.3, "thrombocytosis": 15.91, "transaminases increased": 2.66, "treatment failure": 8.5, "white blood cell count increased": 4.03}